These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32426734)

  • 1. Comparison of IV Insulin Dosing Strategies for Hyperkalemia in the Emergency Department.
    Moussavi K; Nguyen LT; Hua H; Fitter S
    Crit Care Explor; 2020 Apr; 2(4):e0092. PubMed ID: 32426734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced alternative insulin dosing in hyperkalemia: A meta-analysis of effects on hypoglycemia and potassium reduction.
    Moussavi K; Garcia J; Tellez-Corrales E; Fitter S
    Pharmacotherapy; 2021 Jul; 41(7):598-607. PubMed ID: 33993515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Insulin Dosing Strategies for Hyperkalemia Management at an Academic Medical Center.
    Cook ME; Tran LK; DeGrado JR; Alkazemi A; Marino KK
    Clin Ther; 2024 May; 46(5):382-388. PubMed ID: 38594106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparison of Insulin Doses for the Treatment of Hyperkalemia in Patients with Renal Insufficiency.
    LaRue HA; Peksa GD; Shah SC
    Pharmacotherapy; 2017 Dec; 37(12):1516-1522. PubMed ID: 28976587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating Risk Factors for Developing Hypoglycemia During Treatment of Hyperkalemia With Intravenous Regular Insulin.
    Beard MM; McKenzie JJ; Potter TG; Varney Gill K
    J Pharm Pract; 2024 Oct; 37(5):1091-1098. PubMed ID: 38178363
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of standard- vs reduced-dose insulin for treatment of hyperkalemia: A quasi-experiment.
    Pearson SC; O'Connor K; Keller K; Hodge TJ; Nesbit R
    Am J Health Syst Pharm; 2022 Feb; 79(Suppl 1):S13-S20. PubMed ID: 34597356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a Standardized Treatment Panel on Hypoglycemic Events in Hospitalized Acute Hyperkalemic Patients Treated With Intravenous Regular Insulin.
    Zuern A; Probst LA; Darko W; Rosher P; Miller CD; Gordon L; Seabury R
    Hosp Pharm; 2020 Aug; 55(4):240-245. PubMed ID: 32742012
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimal Dose and Method of Administration of Intravenous Insulin in the Management of Emergency Hyperkalemia: A Systematic Review.
    Harel Z; Kamel KS
    PLoS One; 2016; 11(5):e0154963. PubMed ID: 27148740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced Versus Conventional Dose Insulin for Hyperkalemia Treatment.
    Garcia J; Pintens M; Morris A; Takamoto P; Baumgartner L; Tasaka CL
    J Pharm Pract; 2020 Jun; 33(3):262-266. PubMed ID: 30189765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoglycemia Associated With Insulin Use During Treatment of Hyperkalemia Among Emergency Department Patients.
    Jacob BC; Peasah SK; Chan HL; Niculas D; Shogbon Nwaesei A
    Hosp Pharm; 2019 Jun; 54(3):197-202. PubMed ID: 31205332
    [No Abstract]   [Full Text] [Related]  

  • 11. Decreasing Hypoglycemia following Insulin Administration for Inpatient Hyperkalemia.
    Tran AV; Rushakoff RJ; Prasad P; Murray SG; Monash B; Macmaster H
    J Hosp Med; 2020 Feb; 15(2):368-370. PubMed ID: 32039749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current hyperkalemia interventions co-administered with a dextrose 10% solution significantly lower hypoglycemic rates (CHICA-D10).
    Ibarra F; Fountain C; Fallert T
    Am J Emerg Med; 2024 Aug; 84():120-123. PubMed ID: 39111100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5 versus 10 Units of Intravenous Insulin for Hyperkalemia in Patients With Moderate Renal Dysfunction.
    Finder SN; McLaughlin LB; Dillon RC
    J Emerg Med; 2022 Mar; 62(3):298-305. PubMed ID: 35058093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Retrospective Analysis of Intravenous Insulin versus Insulin and Nebulized Albuterol for the Treatment of Hyperkalemia in the Emergency Department.
    Roach SN; Fletcher ML; Sarangarm P
    J Clin Pharmacol; 2024 May; 64(5):619-625. PubMed ID: 38100157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of dextrose 50 bolus versus dextrose 10 infusion in the management of hyperkalemia in the ED.
    Yang I; Smalley S; Ahuja T; Merchan C; Smith SW; Papadopoulos J
    Am J Emerg Med; 2020 Mar; 38(3):598-602. PubMed ID: 31837905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a Hyperkalemia Protocol Tailored to Glucose Concentration and Renal Function on Insulin-Induced Hypoglycemia in Patients with Low Pretreatment Glucose.
    Dybdahl D; Roberson T; Rasor E; Kline L; Pershing M
    J Emerg Med; 2024 Apr; 66(4):e421-e431. PubMed ID: 38462394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting hypoglycemia after treatment of hyperkalemia with insulin and glucose (Glu-K60 score).
    Kijprasert W; Tarudeeyathaworn N; Loketkrawee C; Pimpaporn T; Pattarasettaseranee P; Tangsuwanaruk T
    BMC Emerg Med; 2022 Nov; 22(1):179. PubMed ID: 36371171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of Hypoglycemia in Patients With Low eGFR Treated With Insulin and Dextrose for Hyperkalemia.
    Pierce DA; Russell G; Pirkle JL
    Ann Pharmacother; 2015 Dec; 49(12):1322-6. PubMed ID: 26416951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Hyperkalemia With Insulin and Glucose: Pearls for the Emergency Clinician.
    Moussavi K; Fitter S; Gabrielson SW; Koyfman A; Long B
    J Emerg Med; 2019 Jul; 57(1):36-42. PubMed ID: 31084947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoglycemia in the treatment of hyperkalemia with insulin in patients with end-stage renal disease.
    Apel J; Reutrakul S; Baldwin D
    Clin Kidney J; 2014 Jun; 7(3):248-50. PubMed ID: 25852884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.